ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02684006
Recruitment Status : Active, not recruiting
First Posted : February 17, 2016
Last Update Posted : July 17, 2018
Sponsor:
Information provided by (Responsible Party):
Pfizer

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : December 2, 2018
  Estimated Study Completion Date : April 30, 2021